Pacific Wealth Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$241K Sell
2,184
-3,217
-60% -$311K 0.11% 20
2026
Q2
$423K Hold
5,401
– – 0.19% 12
2026
Q1
$349K Buy
+5,401
New +$381K 0.19% 13

Other funds holding HALO

Pacific Wealth Management's HALO Position: Q3 2026 in Review

Pacific Wealth Management reduced its Halozyme (HALO) stake by 60% in Q3 2026, selling an estimated $311K and leaving 2,184 shares worth $241K. The position accounts for 0.11% of the portfolio, ranked #20.

Pacific Wealth Management first reported a position in HALO in Q1 2026 and has held it in 3 quarters since. The position peaked at $423K in Q2 2026. 31 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Pacific Wealth Management held 2,184 shares of Halozyme worth $241K as of Q3 2026.
  • Pacific Wealth Management sold 3,217 Halozyme shares in Q3 2026, an estimated $311K.
  • Halozyme made up 0.11% of Pacific Wealth Management's portfolio in Q3 2026, its #20 holding.
  • Pacific Wealth Management first reported a position in Halozyme in Q1 2026 and has held it in 3 quarters since.
  • Pacific Wealth Management's Halozyme position peaked at $423K in Q2 2026.
  • 31 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Pacific Wealth Management's 13F filing for Q3 2026, filed 5 Oct 2026.